QS Investors, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2020$452,000
-85.8%
12,150
-80.5%
0.01%
-86.4%
Q2 2020$3,189,000
+62.7%
62,1500.0%0.04%
+41.9%
Q1 2020$1,960,000
-48.6%
62,1500.0%0.03%
-18.4%
Q4 2019$3,813,000
+64.7%
62,150
-1.6%
0.04%
+52.0%
Q3 2019$2,315,000
-21.2%
63,1350.0%0.02%
-21.9%
Q2 2019$2,938,000
+46.3%
63,135
+26.3%
0.03%
+45.5%
Q1 2019$2,008,00050,0000.02%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders